4D Molecular Therapeutics Inc (FDMT)
26.82
+0.08
(+0.30%)
USD |
NASDAQ |
May 07, 16:00
26.82
0.00 (0.00%)
After-Hours: 19:33
4D Molecular Therapeutics EPS Diluted (TTM): -2.66 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -2.66 |
September 30, 2023 | -2.73 |
June 30, 2023 | -3.28 |
March 31, 2023 | -3.38 |
December 31, 2022 | -3.32 |
September 30, 2022 | -3.33 |
June 30, 2022 | -3.36 |
March 31, 2022 | -2.77 |
Date | Value |
---|---|
December 31, 2021 | -2.56 |
September 30, 2021 | -2.480 |
June 30, 2021 | -2.023 |
March 31, 2021 | -2.764 |
December 31, 2020 | -3.041 |
September 30, 2020 | -3.358 |
June 30, 2020 | -4.119 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-4.119
Minimum
Jun 2020
-2.023
Maximum
Jun 2021
-3.012
Average
-3.041
Median
Dec 2020
EPS Diluted (TTM) Benchmarks
Catalent Inc | -7.06 |
Cytokinetics Inc | -5.45 |
Ionis Pharmaceuticals Inc | -2.56 |
Vertex Pharmaceuticals Inc | 13.89 |
Karyopharm Therapeutics Inc | -1.25 |